NFE2L2 and ischemia: Similarly, administration of reEPO also can activate the NRF2 signaling pathway through ERK activation, resulting in neuroprotection in vitro neurotoxin models [89,90] and in vivo brain injury models including ischemia, trauma, and hemorrhage [[91], [92], [93], [94]], as well as an anti-aging effect [95,96].